Home › Funds › Integral Health Asset Management, LLC › REGN
Integral Health Asset Management, LLC position in REGN
REGENERON PHARMACEUTICALS · Health Care
Integral Health Asset Management, LLC reported holding 40,000 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$30.3M, representing 1.97% of its reported portfolio and ranking #11 among its reported holdings. Integral Health Asset Management, LLC has disclosed REGN holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Integral Health Asset Management, LLC's REGN position evolved
Integral Health Asset Management, LLC first disclosed a stake in REGN in Q4 2023 at 25,000 shares (US$22.0M). The position peaked in Q4 2025 at 105,000 shares, worth US$81.0M. Across 8 filings, Integral Health Asset Management, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 40,000 shares valued at US$30.3M. Notable position changes include a 32% trim in Q1 2024 (shares rose 9% over the following quarter), a 110% increase in Q4 2025 (shares were roughly flat over the following quarter), a 53% trim in Q2 2026 (shares rose 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 25.00K | $21.96M | New |
| Q1 2024 | 17.00K | $16.36M | Reduce |
| Q2 2025 | 50.00K | $26.25M | New |
| Q3 2025 | 50.00K | $28.11M | Hold |
| Q4 2025 | 105.00K | $81.05M | Add |
| Q1 2026 | 85.00K | $65.67M | Reduce |
| Q2 2026 | 40.00K | $24.94M | Reduce |
| Q3 2026 | 40.00K | $30.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include DODGE & COX (US$3.62B), Dodge & Cox (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- DODGE & COX 4.77M sh · $3.62B · Q3 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on Integral Health Asset Management, LLC
FAQ
How long has Integral Health Asset Management, LLC held REGN?
Integral Health Asset Management, LLC has disclosed REGN holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
What is Integral Health Asset Management, LLC's current position in REGN?
As of Q3 2026, Integral Health Asset Management, LLC holds 40.00K shares of REGN (REGENERON PHARMACEUTICALS), valued at $30.33M, representing 1.97% of its reported portfolio and ranking #11.
Has Integral Health Asset Management, LLC been buying or selling REGN?
In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in REGN. The position peaked in Q4 2025 at 105.00K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include DODGE & COX, Dodge & Cox, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.